|
|
|
|
| LEADER |
01418 am a22001693u 4500 |
| 001 |
377406 |
| 042 |
|
|
|a dc
|
| 100 |
1 |
0 |
|a Bartczak, Dorota
|e author
|
| 700 |
1 |
0 |
|a Muskens, Otto L.
|e author
|
| 700 |
1 |
0 |
|a Nitti, Simone
|e author
|
| 700 |
1 |
0 |
|a Millar, Timothy M.
|e author
|
| 700 |
1 |
0 |
|a Kanaras, Antonios G.
|e author
|
| 245 |
0 |
0 |
|a Nanoparticles for inhibition of in vitro tumour angiogenesis: synergistic actions of ligand function and laser irradiation
|
| 260 |
|
|
|c 2015-05-01.
|
| 856 |
|
|
|z Get fulltext
|u https://eprints.soton.ac.uk/377406/1/revised_Kanaras_Manuscript.docx
|
| 520 |
|
|
|a Careful design of nanoparticles plays a crucial role in their biomedical applications. It not only defines the stability of nanoparticles in a biological medium but also programs their biological functionality and specific interactions with cells. Here, an inorganic nanoparticulate system engineered to have a dual role as anti-angiogenic and hyperthermic agent is presented. The inorganic rod-shaped core is designed to strongly absorb near-infrared laser irradiation through the surface plasmon resonance and convert it into localized heat, while a peptide coating acts as an anti-angiogenic drug, altogether inhibiting vascular growth. The synergistic dual action provides an improved inhibition of the in vitro tumour angiogenesis, offering new possibilities for the development of nano-engineered anti-angiogenic drugs for therapies.
|
| 655 |
7 |
|
|a Article
|
